ALAI MUMIJO AS A NATURAL MODULATOR OF HEMOSTASIS: EFFECTS ON BLOOD COAGULATION, PLATELET DYNAMICS, AND FIBRINOLYSIS
Keywords:
Alai Mumijo; Shilajit; Blood Coagulation; Anticoagulant; Fibrinolysis; Thrombin Time.Abstract
Mumijo (Shilajit) is a natural herbo-mineral complex recognized for its multifaceted biological activities1. This study evaluated the anticoagulant and fibrinolytic effects of purified Alai mumijo extract in an in vivo canine model. Ten clinically healthy adult dogs (n = 10) received oral aqueous Alai mumijo extract at a dose of 25 mg/kg1. Venous blood samples were collected at baseline, 30 minutes, and 60 minutes post-administration to analyze blood clotting time, plasma recalcification time, thrombin time, heparin tolerance, fibrinolytic activity, and coagulation factor levels1. Oral administration of Alai mumijo significantly extended blood clotting time (>900 vs. 354 ± 30 baseline; p < 0.05 ), plasma recalcification time (149 ± 13 vs. 94 ± 10 ; p < 0.05 ), and thrombin time (72 ± 15 vs. 13 ± 2.2 ; p < 0.05 ). Plasma tolerance to heparin increased significantly at 30 minutes (473 ± 44 vs. 292 ± 34 ), while fibrinolytic activity rose to 136 ± 11 minutes at 60 minutes ( p < 0.05 )1. Coagulation factor activities (Factors V, VII+X) and total plasma protein remained stable throughout. Alai mumijo exerts potent, time-dependent anticoagulant and pro-fibrinolytic actions by suppressing thrombin activity and accelerating fibrinolysis without depleting plasma proteins or coagulation factors.
References
1.Velmurugan, C., et al. Evaluation of safety profile of black shilajit after 91 days repeated administration in rats. Asian Pacific Journal of Tropical Biomedicine, 2012, 2(3), 210-214.
2.Joukar, S., et al. Cardioprotective Effect of Mumie (Shilajit) on Experimentally Induced Myocardial Injury. Cardiovascular Toxicology, 2014, 14, 214-221.
3.Aiello, A., et al. Mumijo Traditional Medicine: Fossil Deposits from Antarctica (Chemical Composition and Beneficial Bioactivity). Evidence-Based Complementary and Alternative Medicine, 2011, 2011, Article ID 738131.
4.Wilson, E., et al. Review on shilajit used in traditional Indian medicine. Journal of Ethnopharmacology, 2011, 136, 1-9.
5.Schepetkin, I. A., et al. Medical Drugs From Humus Matter: Focus on Mumie. Drug Development Research, 2002, 57, 140-159.
6.Agarwal, S. P., et al. Shilajit: A Review. Phytotherapy Research, 2007, 21, 401-405.
7.Schepetkin, I. A., et al. Characterization and Biological Activities of Humic Substances from Mumie. Journal of Agricultural and Food Chemistry, 2003, 51(18), 5245-5254.
8.Barouji, S. R., et al. Health Beneficial Effects of Moomiaii in Traditional Medicine. Galen Medical Journal, 2020, 9, e1743.
9.Tripathi, Y. B., et al. Antilipid Peroxidative Property of Shilajit. Phytotherapy Research, 1996, 10, 269-270.
10.Ghosal, S., et al. Effects of Shilajit and its active constituents on learning and memory in rats. Phytotherapy Research, 1993, 7, 29-34.
11.Schliebs, R., et al. Systemic Administration of Defined Extracts from Withania Somnifera (Indian Ginseng) and Shilajit Differentially Affects Cholinergic But Not Glutamatergic and GABAergic Markers in Rat Brain. Neurochemistry International, 1997, 30(2), 181-190.
12.Ghosal, S. Chemistry of shilajit, an immunomodulatory Ayurvedic rasayan. Pure and Applied Chemistry, 1990, 62(7), 1285-1288.
13.Bhattacharya, S. K., & Ghosal, S. Effect of Shilajit on Rat Brain Monoamines. Phytotherapy Research, 1992, 6, 163-164.
14.Ding, R., et al. Mechanisms of generation and exudation of Tibetan medicine Shilajit (Zhaxun). Chinese Medicine, 2020, 15, 65.
15.Carrasco-Gallardo, C., et al. Shilajit: A Natural Phytocomplex with Potential Procognitive Activity. International Journal of Alzheimer's Disease, 2012, 2012, Article ID 674142.
16.Kloskowski, T., et al. Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment. Scientific Reports, 2021, 11, Article ID 10.1038/s41598-021-01135-2.
17.Bhattacharya, S. K., et al. Effects of Shilajit on biogenic free radicals. Phytotherapy Research, 1995, 9, 56-59.
18.Kanikkannan, N., et al. Shilajit-induced potentiation of the hypoglycemic action of insulin and inhibition of streptozotocin induced diabetes in rats. Phytotherapy Research, 1994, 9, 478-481.
19.Stavropoulos, K., et al. Pseudohyperaldosteronism due to mumijo consumption during pregnancy: a licorice-like syndrome. Gynecological Endocrinology, 2018, 34, 490-494.
20.Kaur, S., et al. Parasympathomimetic Effect of Shilajit Accounts for Relaxation of Rat Corpus Cavernosum. American Journal of Men's Health, 2013, 7(2), 119-127.
21.Mamadaliev, S. I., & Ibragimova, N. M. (2024). The effect of Alai mumiyo on bleeding time and blood loss in rats. Re-Health Journal, (4)24, 39.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal